US Stock MarketDetailed Quotes

MESO Mesoblast

Watchlist
  • 6.000
  • +0.470+8.50%
Close Apr 23 16:00 ET
  • 6.080
  • +0.080+1.33%
Post 19:46 ET
684.43MMarket Cap-6479P/E (TTM)

About Mesoblast Company

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Company Profile

SymbolMESO
Company NameMesoblast
Listing DateNov 13, 2015
Issue Price8.00
Founded2004
CEODr. Silviu Itescu, F.A.C.P.,F.R.A.C.P.,M.B.B.S.
MarketNASDAQ
Employees83
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends06-30
Address55 Collins Street,Level 38
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9639-6036

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Silviu Itescu, F.A.C.P.,F.R.A.C.P.,M.B.B.S.
  • Director and Chief Executive Officer
  • 1.67M
  • Dr. Paul Simmons, PhD
  • Scientific Advisor to the Chief Executive Officer
  • --
  • Dr. Eric A. Rose, M.D.
  • Director and Chief Medical Officer
  • 3.99K
  • Andrew Chaponnel
  • Interim Chief Financial Officer
  • --
  • Dagmar Rosa-Bjorkeson, M.B.A.,M.S.
  • Chief Operating Officer
  • --
  • William J. Burns, B.A.
  • Vice Chairman of the Board
  • 199.24K
  • Joseph R. Swedish
  • Chairman of the Board
  • 372.28K
  • Michael Spooner
  • Independent Director
  • 158.25K
  • Philip J. Facchina
  • Independent Director
  • 203.62K
  • Jane Bell, L.L.B.,L.L.M.
  • Independent Director
  • 209.13K
  • Peter Howard
  • General Counsel
  • --
  • Paul Hughes, B.Bus
  • Joint Company Secretary
  • --
  • Niva Sivakumar
  • Joint Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg